docetaxel anhydrous has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Li, H; Li, Y; Ouyang, J; Wang, J; Wu, L; Zhang, Z; Zuo, L | 1 |
1 other study(ies) available for docetaxel anhydrous and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Lymphoma, Large B-Cell, Diffuse; Paclitaxel; Taxoids; Tumor Cells, Cultured | 2014 |